Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares are trading higher Monday after the company announced it entered into a distribution services agreement with Cardinal Health. The Details: Cities ...
Recursion Pharmaceuticals (NASDAQ: RXRX) didn't have a fine start to the working week on Monday, at least as far as its stock was concerned. Investors traded out of it following the clinical-stage ...
On Monday, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) was awarded an Other Transaction Agreement (OTA) with a potential value of up to $34 million over five years by the Defense Threat Reduction ...
Investor's Business Daily on MSN
Why Novo Nordisk's surprise win hammered Agios Pharmaceuticals stock
Shares of Agios Pharmaceuticals took a header Monday after Novo Nordisk's rival sickle cell treatment succeeded in Phase 3 testing.
We recently published a list of 10 Firms Kick Off Monday Leading Gains. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other firms ...
On Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2 PAVIA trial evaluating Duravyu (vorolanib intravitreal insert), previously known as EYP-1901, in ...
We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against other ...
Shares of Oric Pharmaceuticals (NASDAQ: ORIC) were up more than 19% Monday after rising more than 21% earlier in the day. The clinical-stage biotech company announced a $85 million private placement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results